Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of Glucosamine in Preparation of Radiotherapy Sensitizer

A technology of glucosamine and drugs, applied in the preparation of radiotherapy sensitization drugs, the new application field of glucosamine, which can solve the problems such as no reports of glucosamine radiotherapy sensitization

Active Publication Date: 2019-08-23
SECOND MILITARY MEDICAL UNIV OF THE PEOPLES LIBERATION ARMY
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] There is no report on glucosamine radiosensitization in the prior art

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of Glucosamine in Preparation of Radiotherapy Sensitizer
  • Application of Glucosamine in Preparation of Radiotherapy Sensitizer
  • Application of Glucosamine in Preparation of Radiotherapy Sensitizer

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0029] (1) Cell culture: A549 cells and LLC cells were cultured in DMEM medium containing 10% fetal bovine serum; BEAS-2B cells were cultured in RMPI medium containing 10% fetal bovine serum. All cells were placed at 37°C, 5% CO 2 Cultured in an incubator, subcultured every 2-3 days, and the cells in the logarithmic growth phase were used for experiments.

[0030] (2) CCK-8 colorimetric method: cells in logarithmic growth phase (5*10 4 / mL) were inoculated into 96-well plates, and 6 parallel wells were set up for each concentration. Different concentrations of glucosamine were added to continue culturing for 24 and 48 hours. Add 10 μL CCK-8 reagent to the cell culture medium and continue culturing for 1-4 hours. The absorbance at 450 nm was measured using a microplate reader. Finally, the formula of cell survival rate=dosage group value / control group value×100% was used to calculate the cell survival rate.

[0031] The result is as figure 1 As shown, the results show tha...

Embodiment 2

[0033] (1) Cell culture is the same as in Example 1;

[0034] (2) Cell clone formation method: take A549 cells in the logarithmic growth phase, and inoculate different numbers of cells into six-well plates according to different irradiation dose requirements (0, 2, 4, 8Gy doses of 200, 400, 800 and 1600 cells were inoculated respectively ). After 24 hours, the glucosamine combined with radiation group was treated with 5 mmol / L glucosamine for 1 hour, and the control group was treated with the same amount of PBS as a negative control. The two groups of cells were irradiated with different doses (0-8Gy) of γ-rays at the same time, and continued to culture for 24 hours after irradiation. Both groups were replaced with ordinary medium, and continued to stop the culture until obvious cell clones visible to the naked eye appeared in the culture dish. . Discard the medium, wash twice with PBS, fix with anhydrous methanol for 30 minutes, stain with Gimsa stain for 30 minutes, rinse ...

Embodiment 3

[0036] (1) Cell culture is the same as in Example 1;

[0037] (2) Cell apoptosis detection by flow cytometry: A549 cells and BEAS-2B cells (1*10 5 / mL) into six-well plates, add 5mmol / L glucosamine to treat A549 cells and BEAS-2B cells, then give the cells 8Gy of 60Coγ-ray irradiation, and then continue to culture for 24h, use EDTA-free trypsin to digest the cells After being centrifuged at 1500 rpm for 5 minutes, the cells were washed three times with PBS, and cell apoptosis was detected by flow cytometry after double staining with Annexin V-FITC and PI. The result is as image 3 Shown, the glucosamine (5mmol / L) treatment of non-toxic side effect concentration can obviously increase the radiotherapy sensitivity of A549 cell, but has no radiosensitization effect to BEAS-2B cell: After 5mmol / L glucosamine treats A549 cell, Radiation-induced apoptosis increased by 13%; after 5mmol / L glucosamine treated BEAS-2B cells, radiation-induced apoptosis decreased by 2%. These research...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the field of drugs, in particular to a novel use of glucosamine, i.e., application of the glucosamine in preparing a radiotherapy sensitizating drug. A structural formula of the glucosamine is shown as follows. The glucosamine can be used for preparing the radiotherapy sensitizating drug, and can apparently improve the radiotherapy sensitivity of lung cancer cells at the concentration of nontoxicity and side effect. ( The formula is shown in the description.).

Description

technical field [0001] The invention relates to the field of medicines, in particular to the new application of glucosamine, that is, the application in the preparation of radiosensitizing drugs. Background technique [0002] Lung cancer occurs in the epithelium of the bronchial mucosa, also known as bronchial carcinoma. In the past 50 years, many countries have reported that the incidence of lung cancer has increased significantly. Among male cancer patients, lung cancer has ranked first, and its incidence has also increased rapidly in women, accounting for the second or third of the common malignant tumors in women. The etiology of lung cancer is still not completely clear, but it has seriously affected the life, health and quality of life of patients. Among them, non-small cell lung cancer (NSCLC) includes squamous cell carcinoma, adenocarcinoma, and large cell carcinoma. Compared with small cell carcinoma, the growth and division of the cancer cells are slower, and the ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/7008A61K41/00A61P35/00
Inventor 雷霄杨彦勇蔡建明高福李百龙陈媛媛许洋郭佳铭曹堃刘哲
Owner SECOND MILITARY MEDICAL UNIV OF THE PEOPLES LIBERATION ARMY